News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Auriga Laboratories, Inc. (ARGA.OB) Signs Co-Promotion Agreement With MiddleBrook Pharmaceuticals, Inc. for Keflex(R) 750 mg


1/7/2008 10:02:03 AM

LOS ANGELES, CA--(Marketwire - January 07, 2008) - Auriga Laboratories, Inc. (OTCBB: ARGA), a specialty pharmaceutical company, announced today the signing of a co-promotion agreement with MiddleBrook Pharmaceuticals, Inc., pursuant to which Auriga will co-promote Keflex® 750 mg capsules (cephalexin capsules, USP), to Primary Care Specialists in the U.S.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES